Fidelis Capital Partners, LLC Neogenomics Inc Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 1,383 shares of NEO stock, worth $20,067. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,383Holding current value
$20,067% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$288 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$206 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$140 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$99.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$91.1 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.83B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...